Annual Drug Patent Expirations for AVYCAZ
Avycaz is a drug marketed by Allergan and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug.
This drug has one hundred and eigthy patent family members in fifty-four countries.
The generic ingredient in AVYCAZ is avibactam sodium; ceftazidime. One supplier is listed for this compound. Additional details are available on the avibactam sodium; ceftazidime profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com